| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | DOCUSATE SODIUM AND SENNA | 2 | |
| Docusate sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 3 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | Doc | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Alprazolam Tablets, USP | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM TABLETS, USP 0.25 mg, 0.5 mg, 1 mg and 2 mg | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Alprazolam Tablets, USP | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM | 5 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | DOCUSATE SODIUM | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM TABLETS, USP CIV Rx only | 2 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | Drug Facts | 2 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | 0fbb189e-62f3-d9bb-cd48-d88e0648eb50 | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM TABLETS, USP CIV | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | CitraNatal ® Rx | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | HYDROCHLOROTHIAZIDE CAPSULES USP | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | These highlights do not include all the information needed to use TRICOR safely and effectively. See full prescribing information for TRICOR. TRICOR (fenofibrate) Tablet for oral use Initial U.S. Approval: 1993 | 2 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | Drug Facts | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | These highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993 | 3 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg (Double Strength) and 400 mg/80 mg | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Alprazolam Tablets, USP | 2 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | E-Vac Plus | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | These highlights do not include all the information needed to use Megace ES safely and effectively. See full prescribing information for Megace ES. Megace ES (megestrol acetate, USP) Oral Suspension Initial U.S. Approval: 1993 ® ® ® | 3 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | These highlights do not include all the information needed to use finasteride tablets USP safely and effectively. See full prescribing information for finasteride tablets USP. Finasteride Tablets USP Initial U.S. Approval: 1992 | 1 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | DOCUSATE SOD SENNA 50 8 6MG FOR RUGBY | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Alprazolam Tablets, USP CIV | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM TABLETS, USP CIV Rx only | 1 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | Promolaxin™ Docusate Sodium Stool Softener | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | CICLOPIROX GEL 0.77% | 6 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Prednisone Tablets USP Revised: September 2008 Rx only 173666 | 1 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | Drug Facts | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | SohMed™ Allergy Sinus | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS USP | 2 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | Unknown Title | 2 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | Senna and Docusate Sodium Film Coated Red Tablets 8.6 mg/ 50 mg Laxative | 5 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | Laxacin Laxative Plus Stool Softener | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | CHLORZOXAZONE TABLETS, USP 500 mg Revised: November 2010 Rx only 195609 | 3 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg (Double Strength) and 400 mg/80 mg | 3 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | Docusate Sodium, USP 100mg | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Inflam-X | 1 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | 4a91eee4-6808-45a6-9df1-274a6ad990b4 | 2 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | Drug Facts | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | DOXYCYCLINE HYCLATE TABLETS, USP | 2 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | Non-Habit Forming Stool Softener Laxative | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | GRISEOFULVIN ORAL SUSPENSION (microsize) USP, 125 mg/5 mL Rx Only | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | 86d1eec6-fb4d-42da-86f4-16ecd9f6a0df | 6 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | DOXYCYCLINE HYCLATE TABLETS, USP | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | CHLORZOXAZONE TABLETS, USP 500 mg Revised: November 2010 Rx only 195609 | 2 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | Docusate Sodium ES | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Drug Facts | 5 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Alprazolam Tablets, USP CIV | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS USP, 800 mg/160 mg | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | HYDROCHLOROTHIAZIDE CAPSULES USP | 3 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Minoxidil Tablets USP Revised: June 2009 Rx only 190799 | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use finasteride tablets USP safely and effectively. See full prescribing information for finasteride tablets USP. Finasteride Tablets USP Initial U.S. Approval: 1992 RX only | 7 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | TARKA® (trandolapril/verapamil hydrochloride ER tablets) | 2 | |
| docusate sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | These highlights do not include all the information needed to use EPIDUO Gel safely and effectively. See full prescribing information for EPIDUO Gel. EPIDUO (adapalene and benzoyl peroxide) Gel 0.1%/2.5% For topical use Initial U.S. Approval: 2008 | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | These highlights do not include all the information needed to use C arisoprodol Tablets USP safely and effectively. See full prescribing information for carisoprodol . C arisoprodol Tablets for Oral use Initial U.S. Approval: 1959 | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | CHLORZOXAZONE TABLETS, USP 500 mg Revised: November 2010 Rx only 195609 | 3 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | DOXYCYCLINE HYCLATE TABLETS, USP | 1 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | Non-Habit Forming Stool Softener Laxative | 2 | |
| docusate sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | Dulcolax ® | 1 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | Drug Facts | 2 | |
| docusate sodium | ACTIVE INGREDIENT | F05Q2T2JA0 | f6e923e8-46e8-4287-bd62-5b954829cd73 | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Alprazolam Tablets, USP CIV | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg (Double Strength) and 400 mg/80 mg | 1 | |
| Docusate Sodium | ACTIVE INGREDIENT | F05Q2T2JA0 | Drug Facts | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | CHLORZOXAZONE TABLETS, USP 500 mg Revised: November 2010 Rx only 195609 | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Gabazolamine | 13 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Sentrazolam AM-0.25 | 9 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Gabazolamine-0.5 | 8 | |
| docusate sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | Alprazolam Tablets, USP CIV | 1 | |
| docusate sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | Alprazolam Tablets | 4 | |
| docusate sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | Alprazolam tablets | 5 | |
| Docusate Sodium | ACTIVE INGREDIENT | F05Q2T2JA0 | CitraNatal Harmony ® Rx Prenatal Vitamin Gel Cap | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | These highlights do not include all the information needed to use Megace® ES safely and effectively. See full prescribing information for Megace® ES. Megace ES (megestrol acetate) Oral Suspension Initial U.S. Approval: 1993 | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | DOXYCYCLINE HYCLATE TABLETS, USP | 4 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Rifampin Capsules, USP | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | TRIAZOLAM Tablets, USP 0.125 mg and 0.25 mg CIV | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Sulfamethoxazole and Trimethoprim Tablets, USP | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | b4cd760f-2ebd-4789-9e53-42141e3def1f | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | TRANZGEL HOMEOPATHIC TRANSDERMAL PAIN RELIEF GEL | 5 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | TRANZGEL HOMEOPATHIC TRANSDERMAL PAIN RELIEF GEL | 2 | |
| docusate sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | CHLORZOXAZONE TABLETS, USP 500 mg 0542 | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | HYDROCHLOROTHIAZIDE | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Finasteride Tablets USP, 5 mg RX Only | 4 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | drug facts | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | drug facts | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Triazolam tablets, USP CIV | 1 | |
| docusate sodium | ACTIVE INGREDIENT | F05Q2T2JA0 | Colace 50 mg | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | TRICOR® 48 mg and 145 mg (fenofibrate tablets) | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ETHAMBUTOL HYDROCHLORIDE TABLETS, USP | 3 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | INATAL ADVANCE Tablet 63044-153-64 | 4 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | INATAL Ultra | 4 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | Desoximetasone Cream USP, 0.05%, Cream USP, 0.25% Gel USP, 0.05% | 1 | |
| docusate sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | Alprazolam Tablets, USP | 1 | |
| docusate sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | Prednisone Tablets USP Revised: April 2008 Rx only 2000260-01 | 4 | |
| docusate sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | Clonazepam Tablets USP Rx only C-IV | 1 | |
| docusate sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | Hydroxyzine Pamoate Capsules USP Rx only | 1 | |
| docusate sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | f82dcff5-4afa-45d8-bc8c-f0f7c0c96272 | 1 | |
| docusate sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | Tolinase ® tolazamide tablets, USP | 1 | |
| docusate sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 32751 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | PREDNISONE TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3927 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3866 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3865 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | FENOFIBRATE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3813 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | TRICOR (FENOFIBRATE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3677 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | DOXYCYCLINE (DOXYCYCLINE HYCLATE) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3533 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | DOXYCYCLINE (DOXYCYCLINE HYCLATE) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3347 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | PREDNISONE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3274 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM (ALPRAZOLAM) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3217 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM (ALPRAZOLAM) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3180 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM (ALPRAZOLAM) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3176 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | TRANZGEL (ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, ACONITUM NAPELLUS, ARNICA MONTANA, CALENDULA OFFICIANALIS, HAMAMELIS VIRGINIANA, BELLADONNA, BELLIS PERENNIS, CHAMOMILLIA, MILLEFOLIUM, HYPERICUM PERFORATUM, SYMPHYTUM OFFICINALE, COLCHICINUM) GEL [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3162 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | CHLORZOXAZONE TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3135 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | TARKA (TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ABBVIE INC.] | 1453 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | TRICOR (FENOFIBRATE) TABLET [ABBVIE INC.] | 1426 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLET [BRYANT RANCH PREPACK] | 1002 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM TABLET [BRYANT RANCH PREPACK] | 1001 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM TABLET [BRYANT RANCH PREPACK] | 1000 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | CARISOPRODOL TABLET [BRYANT RANCH PREPACK] | 1000 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | DOCUSATE SODIUM AND SENNA (DOCUSATE SODIUM AND SENNA ) TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1000 | |